Arabic Arabic English English French French German German
dark

New gene editing strategies developed for Duchenne muscular dystrophy

UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based tools to restore a large section of the dystrophin protein that is missing in many DMD patients. The approach, described online today in the journal Science Advances, could lead to a treatment for DMD and inform the treatment of other inherited diseases. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Liberty Company Insurance Brokers forms partnership with Florida-based Darr Schackow Insurance

Next Post

Culturally based online peer support group brought mental health benefits during COVID-19

Related Posts
Total
0
Share